Modernizing Compliance Training To Meet The Evolving Demands Of Life Sciences
In the high-stakes life sciences industry, failing to follow the industry’s copious rules and regulations can be costly. According to a study of 26 large drug firms published in the Journal of the American Medical Association, 85% received financial penalties over a 14-year period. Fines for activities like pricing violations, off-label marketing and kickbacks cost companies $33 billion combined.
This whitepaper shares suggestions for modernizing your compliance training strategies to ensure your employees are up to speed on any new (and existing) regulations so that business expectations are met and your brand reputation is protected.